Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders
Conditions
Interventions
Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: prescribed according to the totality of symptoms. potency ,dose and repetition will be as per homoeopathic principle. all the medicine will be admi
Sponsors
Dr Sumera
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged 18 65 years diagnosed with Generalized Anxiety Disorder as per Diagnostic and statistical manual of mental disorder 5 Text Revision diagnostic criteria. 2.Participants of all gender and from all socioeconomic and religious backgrounds will be included. 3.Patients with Hamilton Anxiety scale defined mild 8 14 and moderate 15 23 anxiety are included. 4.Participants willing to participate and giving written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients who develop severe anxiety during the study period such cases will be referred for appropriate care and excluded from the study 2.Patient currently receiving allopathic medications for anxiety disorder. 3.Presence of psychiatric comorbidities such as schizophrenia, bipolar disorder, severe depression with suicidal risk. 4.Presence of unstable or serious medical illnesses such as uncontrolled diabetes, thyroid disease, cardiovascular disease, hepatic or renal failure, neurological disorders that may interfere with treatment or assessment. 5.Pregnant and lactating mother 6.Patient taking homoeopathic medicine for any other systemic disease since last 6 month 7.Simultaneous participation in any other clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered instrument for assessing the severity of generalized anxiety disorder. Timepoint: assessment at baseline and after 3 months of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)The causal relationship between the intervention and the clinical outcome will be evaluated using the Modified Naranjo Criteria for Homeopathy (MONARCH) 2) Based on the MONARCH score, the therapeutic outcome will be categorized as: (Certain equal or more than 9, Probable 5 8, Possible 1 4, Unlikely equal or less than 0). 3)ADR probability scale will be used to assess the adverse drug reactions (if any) throughout the study. Timepoint: Timepoint: will be measured after 3 months of treatment. | — |
Countries
India
Contacts
Public ContactDr Sumera
National Institute Of Homoeopathy, Delhi, A-8,Chaudhary Ramdev Chowk, Narela, Delhi-110040
Outcome results
None listed